Evidence map›Paper›PMID 42699837›Full record

ArticleCureus2026

Effects of Heart Rate-Synchronized Breathing on Anaerobic Threshold During Incremental Exercise Testing: A Preliminary Case Series.

Dai Kawakita

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Dai KawakitaFaculty of Health and Medical Sciences, Department of Physical Therapy, Teikyo Heisei University, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart rate-synchronized breathing (HRSB) -- a technique in which the respiratory cycle is entrained to the cardiac cycle -- may optimize autonomic nervous function and ventilatory efficiency, potentially improving exercise tolerance. However, its effect on the anaerobic threshold (AT) remains unclear. This study examined the influence of HRSB on AT and related physiological indices during incremental cycle ergometry in healthy young adults. Three healthy male adults (mean age: 22.3 ± 1.2 years) underwent two cardiopulmonary exercise tests on separate days: Day 1 (normal breathing, control) and Day 2 (HRSB intervention). During HRSB, participants inhaled for 2 heartbeats and exhaled for 4 heartbeats (2:4 ratio) guided by auditory cardiac-cycle cues. Respiratory-cardiac entrainment rate, AT oxygen uptake (AT-VO₂), ventilatory equivalent for oxygen (VE/VO₂), and subjective rating of perceived exertion (RPE) were compared within individuals. Participants A and B demonstrated improvements in AT-VO₂ (+2.0 and +1.3 mL/min/kg, respectively), reductions in VE/VO₂ (25.0 to 22.1 and 24.3 to 21.8), and lower RPE scores (13 to 11 and 13 to 12). Participant C showed a marked decline in AT-VO₂ (-4.9 mL/min/kg) and a substantial increase in VE/VO₂ (16.0 to 25.7), indicating deteriorated ventilatory efficiency. HRSB may improve exercise tolerance and ventilatory efficiency in some individuals, likely through enhanced parasympathetic activity and baroreflex sensitivity. However, outcomes varied markedly between participants, suggesting that individual differences in autonomic response and respiratory control capacity significantly moderate the effect. Future studies with larger samples and individualized resonance-frequency assessment are warranted.

Indexed as

anaerobic threshold (at)cardiopulmonary exercise testing (cpx)exercise toleranceheartbeat-synchronized breathingrespiratory sinus arrhythmia (rsa)

Identifiers

PMID42699837
PMCPMC13544610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.